At this year’s Asembia AXS24 Summit, ADVI Health chief commercial officer, Sarah Butler, and solution leader for Federal and State Policy, Lindsay Bealor Greenleaf, sat down with Mark Hansen and Scott Howell for their Prescription for Better Access podcast to discuss their session, “2024 Election Policy Issues and the Patient Journey Ripple Effect: IRA, the War on Cancer, and More.” Their extended conversation expands on insights for the upcoming election, the current status of the Inflation Reduction Act (IRA), and future implications for drug pricing.

 

Hear more on their discussion with Mark and Scott in their most recent episode of Prescription for Better Access.